The European Research Council (ERC) is supporting three scientists in their research projects at the Helmholtz Zentrum München (HMGU) with a total sum just under six million Euros. Prof. Dr. Daniel Razansky, head of the "Multiscale Functional and Molecular Imaging Group" at the Institute of Biological and Medical Imaging, PD Dr. med. Irmela Jeremias, head of the "Apoptosis" group in the Gene Vectors Research Unit and Prof. Dr. Mathias Heikenwälder, head of the "Inflammation induced tissue damage" junior group at the Institute of Virology have each received just under two million euros for their research projects.
The HMGU has been awarded 14 ERC grants up to this year, placing it at the top of the Helmholtz Association in terms of the number of grants. The HMGU’s particularly remarkable triple award of the ERC Consolidator Grants underscores the Center's scientific excellence. This type of grant is intended to support young scientists on the way to consolidate their independent research and also to counteract the “brain drain”, where talent disappears abroad.
For example, Razansky is examining a new, non-invasive method to visualize fast spatio-temporal activity patterns of large neural cell populations in whole living brain. "Observations of this type are currently not possible. If our work is successful, vast progress in our understanding of brain’s function and development of new treatments for neurological and psychiatric disorders is expected," says Razansky.
Jeremias is examining, how tumours of individual patients are treated in a targeted fashion. "The challenge is to understand which genetic anomalies are crucial for individual tumours," explains Jeremias. "If we align the treatment against an essential lesion, we make tumours shrink." Using acute leukaemia as model illness and tumour cells from Munich patients, she develops precise, personalized treatments.
Heikenwälder received the award for research into the cellular and metabolic activation of the immune response in the development of non-alcoholic fatty liver and liver tumours in humans. "With the steady rise in the population’s obesity, we are seeing increased occurrence of non-alcoholic fatty liver and the metabolic syndrome associated with it, as well as diabetes and liver cancer," Heikenwälder explains.
“The origin of the illness is not precisely known, however, and consequently there is currently no efficient treatment to reduce the fatty liver and liver cancer development." Heikenwälder is tracking down an interaction between immune system cytotoxic T-cells and liver cells that lead to the liver disorder. In his project he is investigating molecular mechanisms that lead to fatty liver disease and liver tumours. A better understanding of these processes is opening up new approaches to further treatments.
The ERC (European Research Council) supports the highest quality research in Europe with competition-based financing. Its objective is to establish and solidify European research as cutting-edge research. https://erc.europa.eu/
As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. http://www.helmholtz-muenchen.de/en/index.html
TheInstitute for für Biological and Medical Imaging (IBMI) conducts research into in vivo imaging technologies for the biosciences. It develops systems, theories and methods of imaging and image reconstruction as well as animal models to test new technologies at the biological, preclinical and clinical level. The aim is to provide innovative tools for biomedical laboratories, for diagnosis and for the therapeutic monitoring of human diseases.
Link to portait and video von Prof. Daniel Razansky http://www.helmholtz-muenchen.de/en/research/research-excellence/portraits-of-re...
TheInstitute of Virology (VIRO) German Research Center for Environmental Health, Helmholtz Zentrum München investigates viruses that chronically infect humans and can cause life-threatening diseases. The research activities of the institute focus mainly on the HI virus which causes AIDS, on endogenous retroviruses, which are integrated into our germline, and hepatitis B and C viruses, which cause liver cirrhosis and hepatocellular carcinoma. Molecular studies identify new diagnostic and therapeutic concepts to prevent and treat these viral diseases or to prevent the formation of virus-induced tumors.
Link to portrait and video of Prof. Dr. Mathias Heikenwälder http://www.helmholtz-muenchen.de/en/research/research-excellence/portraits-of-re...
Susanne Eichacker | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)
ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
25.04.2018 | Power and Electrical Engineering
25.04.2018 | Medical Engineering
25.04.2018 | Power and Electrical Engineering